Villani V - Search Results

1

Factors affecting ¹⁸F FDOPA standardized uptake value in patients with primary brain tumors after treatment.

Chiaravalloti A, Fiorentini A, Villani V, Carapella C, Pace A, Di Pietro B, Di Russo C, Palumbo B, Floris R, Schillaci O. Chiaravalloti A, et al. Among authors: villani v. Nucl Med Biol. 2015 Apr;42(4):355-9. doi: 10.1016/j.nucmedbio.2015.01.002. Epub 2015 Jan 9. Nucl Med Biol. 2015. PMID: 25624151 Clinical Trial.

2

Quality of care and rehospitalization rate in the last stage of disease in brain tumor patients assisted at home: a cost effectiveness study.

Pace A, Di Lorenzo C, Capon A, Villani V, Benincasa D, Guariglia L, Salvati M, Brogna C, Mantini V, Mastromattei A, Pompili A. Pace A, et al. Among authors: villani v. J Palliat Med. 2012 Feb;15(2):225-7. doi: 10.1089/jpm.2011.0306. J Palliat Med. 2012. PMID: 22339327

3

Epilepsy in the end-of-life phase in patients with high-grade gliomas.

Pace A, Villani V, Di Lorenzo C, Guariglia L, Maschio M, Pompili A, Carapella CM. Pace A, et al. Among authors: villani v. J Neurooncol. 2013 Jan;111(1):83-6. doi: 10.1007/s11060-012-0993-2. Epub 2012 Oct 20. J Neurooncol. 2013. PMID: 23086435

4

Cognitive impairment in primary brain tumors outpatients: a prospective cross-sectional survey.

Zucchella C, Bartolo M, Di Lorenzo C, Villani V, Pace A. Zucchella C, et al. Among authors: villani v. J Neurooncol. 2013 May;112(3):455-60. doi: 10.1007/s11060-013-1076-8. Epub 2013 Feb 16. J Neurooncol. 2013. PMID: 23417320

5

IDH1 mutation and MGMT methylation status predict survival in patients with anaplastic astrocytoma treated with temozolomide-based chemoradiotherapy.

Minniti G, Scaringi C, Arcella A, Lanzetta G, Di Stefano D, Scarpino S, Bozzao A, Pace A, Villani V, Salvati M, Esposito V, Giangaspero F, Enrici RM. Minniti G, et al. Among authors: villani v. J Neurooncol. 2014 Jun;118(2):377-383. doi: 10.1007/s11060-014-1443-0. Epub 2014 Apr 20. J Neurooncol. 2014. PMID: 24748470

6

Activity and safety of bevacizumab plus fotemustine for recurrent malignant gliomas.

Vaccaro V, Fabi A, Vidiri A, Giannarelli D, Metro G, Telera S, Vari S, Piludu F, Carosi MA, Villani V, Cognetti F, Pompili A, Marucci L, Carapella CM, Pace A. Vaccaro V, et al. Among authors: villani v. Biomed Res Int. 2014;2014:351252. doi: 10.1155/2014/351252. Epub 2014 May 4. Biomed Res Int. 2014. PMID: 24877084 Free PMC article. Clinical Trial.

7

Home palliative care and end of life issues in glioblastoma multiforme: results and comments from a homogeneous cohort of patients.

Pompili A, Telera S, Villani V, Pace A. Pompili A, et al. Among authors: villani v. Neurosurg Focus. 2014 Dec;37(6):E5. doi: 10.3171/2014.9.FOCUS14493. Neurosurg Focus. 2014. PMID: 25434390

8

Home care for brain tumor patients.

Pace A, Villani V, Di Pasquale A, Benincasa D, Guariglia L, Ieraci S, Focarelli S, Carapella CM, Pompili A. Pace A, et al. Among authors: villani v. Neurooncol Pract. 2014 Mar;1(1):8-12. doi: 10.1093/nop/npt003. Neurooncol Pract. 2014. PMID: 26034609 Free PMC article.

9

The Role of PET [18F]FDOPA in Evaluating Low-grade Glioma.

Villani V, Carapella CM, Chiaravalloti A, Terrenato I, Piludu F, Vidiri A, Schillaci O, Floris R, Marzi S, Fabi A, Pace A. Villani V, et al. Anticancer Res. 2015 Sep;35(9):5117-22. Anticancer Res. 2015. PMID: 26254416

10

The Prognostic Value of Pyrosequencing-Detected MGMT Promoter Hypermethylation in Newly Diagnosed Patients with Glioblastoma.

Villani V, Casini B, Pace A, Prosperini L, Carapella CM, Vidiri A, Fabi A, Carosi M. Villani V, et al. Dis Markers. 2015;2015:604719. doi: 10.1155/2015/604719. Epub 2015 Aug 11. Dis Markers. 2015. PMID: 26347581 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

209 results

Search Page

Filters